UBS Group AG - SENSEI BIOTHERAPEUTICS INC ownership

SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 43 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of SENSEI BIOTHERAPEUTICS INC
ValueSharesWeighting
Q2 2023$7,423
+43.9%
6,511
+89.3%
0.00%
Q1 2023$5,160
+215.6%
3,440
+213.6%
0.00%
Q4 2022$1,635
-91.8%
1,097
-91.6%
0.00%
Q3 2022$20,000
-35.5%
13,114
-2.6%
0.00%
Q2 2022$31,0000.0%13,463
-1.1%
0.00%
Q1 2022$31,000
-76.2%
13,618
-39.2%
0.00%
Q4 2021$130,000
+1081.8%
22,402
+2120.2%
0.00%
Q3 2021$11,000
+57.1%
1,009
+45.4%
0.00%
Q2 2021$7,000
-77.4%
694
-66.9%
0.00%
Q1 2021$31,0002,0990.00%
Other shareholders
SENSEI BIOTHERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Duquesne Family Office 100,000$231,0000.01%
FNY Investment Advisers, LLC 3,500$8,0000.01%
LEO BROKERAGE, LLC 14,845$34,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 37,900$88,0000.00%
UBS Group AG 13,618$31,0000.00%
RHUMBLINE ADVISERS 16,169$37,0000.00%
Ellevest, Inc. 19$00.00%
TWO SIGMA INVESTMENTS, LP 62,184$144,0000.00%
FMR LLC 179$00.00%
AMERICAN INTERNATIONAL GROUP, INC. 10,375$24,0000.00%
View complete list of SENSEI BIOTHERAPEUTICS INC shareholders